Why Big Pharma Is Betting on Japan's Preclinical CRO Boom
Japan has long been a powerhouse in pharmaceutical research, but the way drugs are tested before human trials is changing fast. More companies are outsourcing preclinical work — toxicology, pharmacology, and biologics testing — to specialized contract research organizations. The result is a rapidly growing market that is attracting attention from global players and investors alike....
0 التعليقات 0 المشاركات 582 مشاهدة 0 معاينة